On the recordSeptember 9, 2024
Mr. Speaker, I rise today to urge my colleagues to join me in supporting H.R. 8333, the BIOSECURE Act. Mr. Speaker, this bill ensures that biotech companies linked to foreign adversaries do not gain access to precious U.S. taxpayer dollars via biotechnology contracts. We cannot allow the CCP-affiliated firms to gain access to U.S. genetic data. We cannot allow ourselves to be dependent on and vulnerable to the CCP for healthcare technologies, products, and services. Otherwise, we risk China using our own health data as leverage against us. We recognize that our biotechnology companies did not arrive at this juncture on their own. Decades of failed policy, unreasonable, burdensome red tape, and a lack of oversight led to this precarious situation of overinvestment in and industrial partnerships with China. We must act in coordination with the biotech sector to correct this imbalance. The BIOSECURE Act accomplishes this. I urge support of this bill. Mr. McGOVERN. Mr. Speaker, may I ask the gentleman how many more speakers he has.





